The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Medifast Inc

NYSE: MED
Last

(U.S.) $56.35

Today's change+0.17 +0.30%
Updated September 22 4:02 PM EDT. Delayed by at least 15 minutes.
 

Medifast Inc

NYSE: MED
Last

(U.S.) $56.35

Today's change+0.17 +0.30%
Updated September 22 4:02 PM EDT. Delayed by at least 15 minutes.

Medifast Inc up (U.S.)$0.17

Medifast Inc closed up Friday by (U.S.)$0.17 or 0.30% to (U.S.)$56.35. Over the last five days, shares are unchanged, but are currently 3.91% below its 52-week high. This security has outperformed the S&P 500 by 31.97% during the last year.

Key company metrics

  • Open(U.S.) $56.35
  • Previous close(U.S.) $56.18
  • High(U.S.) $56.69
  • Low(U.S.) $55.96
  • Bid / Ask-- / --
  • YTD % change+35.36%
  • Volume60,696
  • Average volume (10-day)108,338
  • Average volume (1-month)127,423
  • Average volume (3-month)95,087
  • 52-week range(U.S.) $36.70 to (U.S.) $58.64
  • Beta0.45
  • Trailing P/E28.29×
  • P/E 1 year forward26.58×
  • Forward PEG1.77×
  • Indicated annual dividend(U.S.) $1.28
  • Dividend yield2.27%
  • Trailing EPS(U.S.) $1.99
Updated September 22 4:02 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+8.62%

Based on its net profit margin of 8.62%, Medifast Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.00%Sector:Non-Cyclical Consumer Goods & ServicesIndustry:Food Processing

Latest Press Releases

View more Press Releases
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2017Q1/2017Q4/2016Q3/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201706/30/2017Mar 31, 201703/31/2017Dec 31, 201612/31/2016Sep 30, 201609/30/2016
Revenue76716269
Total other revenue--------
Total revenue76716269
Gross profit58534752
Total cost of revenue18181516
Total operating expense64625660
Selling / general / administrative46444043
Research & development--------
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income11979
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax11979
Income after tax8646
Income tax, total4333
Net income8646
Total adjustments to net income--------
Net income before extra. items8646
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items8646
Inc. avail. to common incl. extra. items8646
Diluted net income8646
Dilution adjustment0------
Diluted weighted average shares12121212
Diluted EPS excluding extraordinary itemsvalue per share0.630.510.340.51
Dividends per sharevalue per share0.320.320.320.25
Diluted normalized EPSvalue per share0.630.510.340.51